Business Context and Reporting Period
This Form 8-K was filed by Marathon Patent Group, Inc. on August 9, 2017, reporting events occurring on August 3, 2017. The company is an emerging growth company incorporated in Nevada, operating primarily in intellectual property licensing and commercialization.
Key Financial Metrics and Agreements
The filing details a restructuring of debt and revenue sharing obligations with DBD Credit Funding LLC (DBD). Key financial terms include:
- Debt Restructuring: Interest payments on notes held by DBD are deferred from May 1, 2017, until the earlier of November 1, 2017, or the Restructuring Effective Date. Accrued interest during this period will be treated as a Cash Advance.
- Liquidity Covenant: The minimum liquidity covenant has been lowered to provide time for the restructuring.
- Revenue Allocation: Proceeds from monetization activities are prioritized to pay third-party costs, then DBD note obligations, then the revenue stream, and finally residuals to DBD and the Company.
- Executive Compensation: A new Consulting Agreement with former officer Erich L. Spangenberg establishes a monthly fee of $20,000 for up to 20 hours of service per week.
The filing does not provide specific values for total revenue, net profit, cash flow, or total debt outstanding as of the reporting date.
Material Changes
Significant changes reported include:
- Asset Transfer: Designated intellectual property (IP) is to be assigned to Special Purpose Entities (SPEs) managed by a DBD affiliate. DBD gains sole discretion over monetization activities for this IP.
- Expense Responsibility: Post-restructuring, the SPE will bear expenses for Designated IP, while the Company retains responsibility for Non-Designated IP.
- Leadership Change: Erich L. Spangenberg's employment was terminated effective August 3, 2017, and he was immediately engaged as an independent consultant.
Outlook, Risks, and Contingencies
Management indicated the company may evaluate strategic alternatives, including business initiatives unrelated to IP licensing. The restructuring is contingent upon shareholder approval and third-party consents. Material risks include events of default such as liquidation, change of control, bankruptcy, or failure to secure necessary consents, which could trigger immediate payment of all outstanding obligations.
Investor Verification Checklist
- Verify the status of shareholder approval for the proposed restructuring and SPE formation.
- Confirm the specific valuation and scope of "Designated IP" versus "Non-Designated IP" to be transferred.
- Review the full text of the First Amendment to the Revenue Sharing Agreement (Exhibit 10.1) for detailed payment waterfall mechanics.
- Assess the impact of the $20,000 monthly consulting fee on future operating expenses.
- Monitor the company's liquidity position given the deferral of interest payments and the lowered liquidity covenant.